PMI Picard Medical, Inc.

Fundamentals / CIK 0002030617 / USD

Picard Medical, Inc. reported $5.33M in revenue and a net loss of $19.79M for the trailing twelve months ended September 30, 2026 (down 81.7% year over year), with a 26.2% gross margin and a -267.2% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open PMI in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

2 fiscal years (2024 to 2025), reported in USD.

$7.72M$3.86M$0-$25.67MFY 2024 Revenue: $4.39MFY 2024 Net Income: -$21.05M2024FY 2025 Revenue: $4.94MFY 2025 Net Income: -$27.00M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31
Revenue $4.94M $4.39M
Cost of Revenue $5.14M $4.50M
Gross Profit -$204K -$112K
Research & Development $3.05M $3.38M
Selling, General & Admin $10.00M $10.22M
Total Operating Expenses $13.05M $13.60M
Operating Income -$13.26M -$13.71M
EBITDA -$13.09M -$13.49M
Income Before Tax -$26.97M -$21.07M
Income Tax Expense $35K -$15K
Net Income -$27.00M -$21.05M
Basic EPS -$37.50 -$149.50
Basic Shares Outstanding 724.7K 158.9K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $217K $2.95M $1.15M $1.01M $1.19M $2.13M $620K --
Cost of Revenue $122K $2.34M $875K $598K $1.32M $2.26M $978K --
Gross Profit $95K $616K $275K $411K -$130K -$127K -$358K --
Research & Development $321K $1.37M $1.90M $547K $951K $743K $808K --
Selling, General & Admin $1.88M $3.87M $2.89M $2.87M $2.41M $2.65M $2.08M --
Total Operating Expenses $2.20M $5.25M $4.79M $3.41M $3.36M $3.39M $2.89M --
Operating Income -$2.10M -$4.63M -$4.51M -$3.00M -$3.49M -$3.52M -$3.25M --
EBITDA -$2.06M -$4.58M -$4.46M -$2.96M -$3.45M -$3.48M -$3.20M --
Interest Expense -- -- -- -- -- $2.43M -- --
Income Before Tax -$2.22M -$5.65M -$7.62M -$4.29M -$10.43M -$6.72M -$5.53M --
Income Tax Expense $0 $7.0K $0 $4.0K $0 $0 $31K --
Net Income -$2.22M -$5.66M -$7.62M -$4.29M -$10.43M -$6.72M -$5.56M -$8.84M
Basic EPS -$0.95 -$152.50 -$5.00 -- -$9.57 -$2,119.50 -$40.00 --
Basic Shares Outstanding 2.3M 37.1K 1.5M -- 1.1M 3.5K 159.3K --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31
Cash & Cash Equivalents $7.45M $96K
Cash & Short-Term Investments $7.45M $96K
Accounts Receivable, Net -- $513K
Inventory $7.30M $8.12M
Total Current Assets $20.73M $9.79M
Property, Plant & Equipment, Net $183K $227K
Goodwill $615K $615K
Intangible Assets $509K $596K
Total Non-Current Assets $1.82M $2.31M
Total Assets $22.55M $12.11M
Accounts Payable $2.08M $5.29M
Other Current Liabilities $499K $493K
Total Current Liabilities $18.70M $35.33M
Total Non-Current Liabilities $64K $517K
Total Liabilities $18.76M $35.84M
Total Debt (incl. Leases) $527K $434K
Common Stock $0 $1.0K
Retained Earnings -$76.84M -$49.84M
Accumulated Other Comp. Income $228K $278K
Total Stockholders' Equity $3.79M -$44.00M
Total Equity $3.79M -$44.00M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2024-12-31
Cash & Cash Equivalents $67K $38K $121K $7.45M $2.81M $410K $96K
Cash & Short-Term Investments $67K $38K $121K $7.45M $2.81M $410K $96K
Accounts Receivable, Net -- -- -- -- -- $1.30M $513K
Inventory $6.38M $5.97M $7.45M $7.30M $6.55M $7.00M $8.12M
Total Current Assets $7.63M $7.59M $9.51M $20.73M $11.59M $9.64M $9.79M
Property, Plant & Equipment, Net $140K $162K $184K $183K $169K $188K $227K
Goodwill $615K $615K $615K $615K $615K $615K $615K
Intangible Assets $443K $465K $487K $509K $531K $553K $596K
Total Non-Current Assets $1.44M $1.57M $1.71M $1.82M $1.93M $2.06M $2.31M
Total Assets $9.06M $9.17M $11.22M $22.55M $13.52M $11.70M $12.11M
Accounts Payable $3.50M $3.32M $2.71M $2.08M $3.12M $6.37M $5.29M
Other Current Liabilities $515K $515K $499K $499K $6.0K $505K $493K
Total Current Liabilities $7.73M $7.45M $12.66M $18.70M $5.37M $45.64M $35.33M
Total Non-Current Liabilities $0 $0 $9.0K $64K $180K $295K $517K
Total Liabilities $7.73M $7.45M $12.67M $18.76M $5.55M $45.93M $35.84M
Total Debt (incl. Leases) $188K $311K $417K $527K $616K $429K $434K
Common Stock $0 $0 $8.0K $0 $7.0K $1.0K $1.0K
Retained Earnings -$92.34M -$90.12M -$84.46M -$76.84M -$72.55M -$62.13M -$49.84M
Accumulated Other Comp. Income $262K $269K $246K $228K $230K $262K $278K
Total Stockholders' Equity $1.33M $1.72M -$1.45M $3.79M $7.97M -$54.49M -$44.00M
Total Equity $1.33M $1.72M -$1.45M $3.79M $7.97M -$54.49M -$44.00M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31
Net Income -$27.00M -$21.05M
Depreciation & Amortization $163K $226K
Stock-Based Compensation $754K $886K
Change in Receivables -$120K $116K
Change in Inventory $390K -$1.33M
Change in Payables -$3.21M $2.21M
Operating Cash Flow -$15.67M -$11.87M
Investing Cash Flow -- $0
Common Stock Issued $15.21M $0
Financing Cash Flow $27.08M $11.74M
Net Change in Cash $11.36M -$148K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$2.22M -$5.66M -$7.62M -$4.29M -$10.43M -$6.72M -$5.56M -$8.84M
Depreciation & Amortization $44K $45K $46K $40K $41K $40K $42K --
Stock-Based Compensation $93K $1.38M $165K $226K $204K $183K $141K --
Change in Receivables $470K -$18K $27K $259K $408K -$1.29M $506K --
Change in Inventory -$483K $1.05M -$321K -$531K $266K $901K -$246K --
Change in Payables $176K $612K $632K -$1.04M -$3.25M $850K $227K --
Operating Cash Flow -$2.00M -$1.35M -$3.80M -$4.38M -$6.51M -$2.54M -$2.24M --
Capital Expenditure $0 $0 -$26K -- $0 $0 $0 --
Free Cash Flow -$2.00M -$1.35M -$3.83M -- -$6.51M -$2.54M -$2.24M --
Investing Cash Flow $0 $0 -$26K -- $0 $0 $0 --
Common Stock Issued $0 $0 $0 $0 $13.72M $985K $500K --
Financing Cash Flow $2.03M $1.25M -$7.52M $13.02M $8.95M $2.28M $2.83M --
Net Change in Cash $29K -$83K -$11.33M $8.64M $2.40M -$278K $592K --

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31
Gross Margin -4.1% -2.6%
Operating Margin -268.4% -312.3%
Net Profit Margin -546.6% -479.5%
Return on Equity (ROE) -712.6% --
Return on Assets (ROA) -119.8% -173.9%
Current Ratio 1.11x 0.28x
Quick Ratio 0.72x 0.05x
Debt to Equity 0.14x --
Revenue Growth (YoY) +12.5% --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Gross Margin 26.2% 18.6% 7.8% -4.1% -- -- -- --
Operating Margin -267.2% -248.1% -265.1% -268.0% -- -- -- --
Net Profit Margin -371.2% -444.3% -530.5% -545.8% -- -- -- --
Return on Equity (ROE) -1487.7% -1631.3% -- -712.6% -395.9% -- -- --
Return on Assets (ROA) -218.3% -305.4% -259.0% -119.8% -233.3% -233.5% -- -173.9%
Current Ratio 0.99x 1.02x 0.75x 1.11x 2.16x 0.21x -- 0.28x
Quick Ratio 0.16x 0.22x 0.16x 0.72x 0.94x 0.06x -- 0.05x
Debt to Equity 0.14x 0.18x -- 0.14x 0.08x -- -- --
Revenue Growth (YoY) -81.7% +38.6% +85.5% -- +34.7% +207.1% -- --
Source: SEC EDGAR CompanyFacts (CIK 0002030617) · from March 31, 2024 Data through September 30, 2026 · synced Nov 20, 2026, 05:32 UTC · Open in terminal